{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:19:51Z","timestamp":1765009191925,"version":"3.46.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00499-z","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:43:15Z","timestamp":1759840995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reclassification of an uncertain STK11 germline variant as likely pathogenic: a family study"],"prefix":"10.1007","volume":"24","author":[{"given":"Lorena","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Cuatrecasas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edriam","family":"Potrony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Oriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Anton","family":"Puig-Butill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabela","family":"Carballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"499_CR1","doi-asserted-by":"crossref","unstructured":"Mcgarrity TJ, Amos CI, Baker MJ et al (2001) Peutz-Jeghers syndrome","DOI":"10.1016\/S0002-9270(99)00890-4"},{"key":"499_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030473","author":"A Wagner","year":"2021","unstructured":"Wagner A, Aretz S, Auranen A et al (2021) The management of Peutz\u2013Jeghers syndrome: European hereditary tumour group (EHTG) guideline. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10030473","journal-title":"J Clin Med"},{"key":"499_CR3","doi-asserted-by":"publisher","unstructured":"Wu B, Da, Wang YJ, Fan LL et al (2020) Clinical and genetic analyses of 38 chinese patients with peutz-jeghers syndrome. Biomed Res Int 2020:. https:\/\/doi.org\/10.1155\/2020\/9159315","DOI":"10.1155\/2020\/9159315"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10689-017-0037-3","volume":"17","author":"J Daniell","year":"2018","unstructured":"Daniell J, Plazzer JP, Perera A, Macrae F (2018) An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review. Fam Cancer 17:421\u2013427","journal-title":"Fam Cancer"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10689-018-0093-3","volume":"18","author":"GI Butel-Simoes","year":"2019","unstructured":"Butel-Simoes GI, Spigelman AD, Scott RJ, Vilain RE (2019) Low-level parental mosaicism in an apparent de Novo case of Peutz\u2013Jeghers syndrome. Fam Cancer 18:109\u2013112. https:\/\/doi.org\/10.1007\/s10689-018-0093-3","journal-title":"Fam Cancer"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10689-020-00191-4","volume":"20","author":"AM Jelsig","year":"2021","unstructured":"Jelsig AM, Bertelsen B, Forss I, Karstensen JG (2021) Two cases of somatic STK11 mosaicism in Danish patients with Peutz\u2013Jeghers syndrome. Fam Cancer 20:55\u201359. https:\/\/doi.org\/10.1007\/s10689-020-00191-4","journal-title":"Fam Cancer"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"104400","DOI":"10.1016\/j.ejmg.2021.104400","volume":"65","author":"E Lucci-Cordisco","year":"2022","unstructured":"Lucci-Cordisco E, Amenta S, Panfili A et al (2022) Variants of uncertain significance (VUS) in cancer predisposing genes: What are we learning from multigene panels? Eur J Med Genet 65:104400. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104400","journal-title":"Eur J Med Genet"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12920-022-01270-4","volume":"15","author":"A Kwong","year":"2022","unstructured":"Kwong A, Ho CYS, Shin VY et al (2022) How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer? BMC Med Genom 15:122. https:\/\/doi.org\/10.1186\/s12920-022-01270-4","journal-title":"BMC Med Genom"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Sci 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Sci"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.gie.2022.02.044","volume":"95","author":"CR Boland","year":"2022","unstructured":"Boland CR, Idos GE, Durno C et al (2022) Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. multi-society task force on colorectal cancer. Gastrointest Endosc 95:1025\u20131047. https:\/\/doi.org\/10.1016\/j.gie.2022.02.044","journal-title":"Gastrointest Endosc"},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gastrohep.2023.06.004","volume":"47","author":"S Carballal","year":"2024","unstructured":"Carballal S, Balaguer F, Bujanda L et al (2024) Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GEN\u00d3MICA consortium. Gastroenterol Hepatol 47:293\u2013318. https:\/\/doi.org\/10.1016\/j.gastrohep.2023.06.004","journal-title":"Gastroenterol Hepatol"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41431-023-01507-5","volume":"32","author":"T McDevitt","year":"2024","unstructured":"McDevitt T, Durkie M, Arnold N et al (2024) EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer. Eur J Hum Genet 32:479\u2013488","journal-title":"Eur J Hum Genet"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly MB, Pal T, Maxwell KN et al (2023) Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024 featured updates to the NCCN guidelines. JNCCN J Natl Compr Cancer Netw 21:1001\u20131010. https:\/\/doi.org\/10.6004\/jnccn.2023.0051","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"499_CR14","doi-asserted-by":"publisher","unstructured":"Gourevitch RA, Rose S, Crockett SD et al (2018) Variation in pathologist classification of colorectal adenomas and serrated polyps. Official J Am Coll Gastroenterol ACG 113(3):431\u2013439. https:\/\/doi.org\/10.1038\/ajg.2017.496","DOI":"10.1038\/ajg.2017.496"},{"key":"499_CR15","doi-asserted-by":"publisher","unstructured":"Gilad O, Rosner G, Fliss-Isakov N et al (2019) Clinical and histologic overlap and distinction among various hamartomatous polyposis syndromes. Clin Transl Gastroenterol 10(5):1\u20139. https:\/\/doi.org\/10.14309\/ctg.0000000000000035","DOI":"10.14309\/ctg.0000000000000035"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00432-018-2763-9","volume":"144","author":"S Bonache","year":"2018","unstructured":"Bonache S, Esteban I, Moles-Fern\u00e1ndez A et al (2018) Multigene panel testing beyond BRCA1\/2 in breast\/ovarian cancer Spanish families and clinical actionability of findings. J Cancer Res Clin Oncol 144:2495\u20132513. https:\/\/doi.org\/10.1007\/s00432-018-2763-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.pec.2022.03.009","volume":"105","author":"J Zhao","year":"2022","unstructured":"Zhao J, Guan Y, McBride CM (2022) A systematic review of theory-informed strategies used in interventions fostering family genetic risk communication. Patient Educ Couns 105:1953\u20131962. https:\/\/doi.org\/10.1016\/j.pec.2022.03.009","journal-title":"Patient Educ Couns"},{"key":"499_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040925","author":"V Baroutsou","year":"2021","unstructured":"Baroutsou V, Underhill-Blazey ML, Appenzeller-Herzog C, Katapodi MC (2021) Interventions facilitating family communication of genetic testing results and cascade screening in hereditary Breast\/Ovarian cancer or Lynch syndrome: a systematic review and meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13040925","journal-title":"Cancers (Basel)"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jgc4.1075","volume":"28","author":"S Makhnoon","year":"2019","unstructured":"Makhnoon S, Shirts BH, Bowen DJ (2019) Patients\u2019 perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns 28:313\u2013325. https:\/\/doi.org\/10.1002\/jgc4.1075","journal-title":"J Genet Couns"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12687-019-00434-7","volume":"11","author":"K Clift","year":"2020","unstructured":"Clift K, Macklin S, Halverson C et al (2020) Patients\u2019 views on variants of uncertain significance across indications. J Community Genet 11:139\u2013145. https:\/\/doi.org\/10.1007\/s12687-019-00434-7","journal-title":"J Community Genet"},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejmg.2018.11.003","volume":"62","author":"RG Resta","year":"2019","unstructured":"Resta RG (2019) What have we been trying to do and have we been any good at it? A history of measuring the success of genetic counseling. Eur J Med Genet 62:300\u2013307. https:\/\/doi.org\/10.1016\/j.ejmg.2018.11.003","journal-title":"Eur J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00499-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:17:27Z","timestamp":1765009047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00499-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00499-z","relation":{},"ISSN":["1573-7292"],"issn-type":[{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The\n                      Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n con medicamentos\n                      from our institution exempted this study because it is a case report, and informed consent from participants was already obtained. Written informed consent for publication was obtained from all participants. Permission was obtained to publish patient photos or images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that the human research participants provided informed consent for the publication of the images in Fig.\u00a02a.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"74"}}